Skip to main content

Legacy Capital Group California, Inc.

Position in NVO — Novo Nordisk A S

CIK 1977092 LOS GATOS, CA

Position in NVO

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$493,734
+$122,780 QoQ
Shares Held
10,299
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#716
of 1,348 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Legacy Capital Group California, Inc. holds $8,650,056 across 9 Drug Manufacturers - General names. NVO ranks #8 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
10,299 $493,734

All Filings in NVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $493,734 10,299
2026-03-31 $370,954 10,094
2025-12-31 $1,002,030 19,694
2025-09-30 $1,061,745 19,134
2025-06-30 $766,329 11,103
2025-03-31 $991,603 14,280
2024-12-31 $559,302 6,502
2024-09-30 $906,122 7,610
2024-06-30 $2,085,288 14,609
2024-03-31 $1,961,695 15,278
2023-12-31 $1,604,819 15,513
2023-09-30 $1,454,676 15,996
2023-06-30 $562,521 3,476
2023-03-31 $339,286 2,132